Turbt – Can we do it better? Yes, we can

Reljić A¹, Tomić M¹, Tomašković I¹, Ulamec M², Krušlin B², Trnski D¹ Dpt. of urology¹ and Dpt. for clinical pathology², University Hospital Center „Sestre milosrdnice“, Zagreb, Croatia   PURPOSE – 43% of invasive bladder cancers (T≥2) arose by means of progression from non-muscle invasive carcinomas (NMIBC) and their prognosis is worse in comparison with primary

Read more